Nontoxic clostridium perfringens and clostridium septicum fusion protein vaccine and production method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHINA INST OF VETERINARY DRUG CONTROL
- Publication Date
- 2019-07-26
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to an avirulent Clostridium perfringens and Clostridium putrefaction fusion protein vaccine and a production method thereof. It belongs to the field of veterinary biological products. Background technique
[0002] Clostridium perfringens and Clostridium putrefaction are anaerobic bacteria that can cause disease in humans and various animals, and are extremely harmful to human health and livestock and poultry breeding. Among them, Clostridium perfringens is one of the main pathogens of traumatic gas gangrene and human food poisoning, sudden gangrene of sheep, lamb dysentery, necrotic enteritis of cattle and sheep, and enterotoxemia of cattle and sheep. The main pathogen of the epidemic. The pathogenic factors of both Clostridia are exotoxins secreted by the bacteria. Clostridium perfringens can be divided into A, B, C, D, E according to the types of four main lethal exotoxins α (CPA), β (CPB), ε (ETX) and ι (CPI) produced. Five...